What is the recommended frequency for re-testing stability samples during long-term studies?
Are there guidelines for stability testing of pediatric and geriatric drug products?
How can I address stability testing for orphan drug products with limited data?
What documentation should be included in stability study reports?
How should I handle stability testing of vaccines and biological products?
Can stability data from one region be used to support registration in another region?
What role does stability testing play in the registration of new drug products?
Are there guidelines for stability testing of radiopharmaceuticals?
How can stability studies be used to establish storage instructions for consumers?
What is the recommended procedure for testing products with limited solubility?